ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 714

Line Blot Assay, a Screening Test for Autoantibodies in Systemic Sclerosis (SSc)

Kae Takagi1, Yasushi Kawaguchi1, Sayuri Kataoka1, Yuko Ota2, Yuko Okamoto1, Masanori Hanaoka1, Hisae Ichida1, Takahisa Gono1, Yasuhiro Katsumata1 and Hisashi Yamanaka1, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute of Rheumatology,Tokyo Women's Medical University, Tokyo, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Autoantibodies and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s – Clinical Aspects and Therapeutics

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Detection of auto-antibody is informative for diagnosis of SSc. Line blot assay (LBA) provides a quantitative in vitro assay for detecting human IgG class auto-antibodies against 13 different antigens simultaneously. The aim of our study is to evaluate availability of LBA for SSc in clinical setting, and assessing the sensitivity comparing with other conventional assay.

Methods:

LBA strips coated with thin parallel lines of 13 synthesized antigen (CENPA, CENPB, U1RNP,  fibrillarin, RNAPIII(RP11�ARP155), NOR90, Th/To, PM-Scl100, PM-Scl75, Ku, Ro-52,  PDGFR ) captures serum auto antibody. Captured autoantibody is detected by Alkaline Phosphatase conjugated second antibody combined with automated scan system. Serum samples from SSc patients in our hospital were investigated. Anti-Scl70 antibody and anti-centromere antibody was also measured using conventional DID assay.

Results:

Serum from 80 SSc patients, 75 female and 5 male patients between 51.7±15.2 years old, were investigated. Eighty SSc patients consisted with 47 diffuse cutaneous SSc (dcSSc) type and 33 limited cutaneous SSc (lcSSc) type patients. Anti nuclear antibody positivity detected by indirect immunofluorescence methods was 92.5%. Higher total skin score (MRSS), complications of lung fibrosis, Raynaud’s phenomena, and arthritis were more frequently observed in dcSSc patients. Sensitivity and specificity of anti-Scl70 antibody using LBA was 90% and 92% respectively. Sensitivity and specificity of anti-centromere antibody using line assay was 87.5 % and 95.5% respectively. Sensitivity against both auto antibodies was much higher in LBA than DID method. Anti U3 RNP antibody, Anti NOR90 antibody and anti Ku antibody was also detected by LBA. Previous reports describe anti Th/To antibody were detected in 5-10 % of SSc patients by immunoprecipitation (IP) method. However, anti Th/To antibody was not detected in this screening using LBA.

We also investigated the relationship between appearance of auto antibody and clinical phenotypes. It is known anti RNA polymerase III antibody positivity correlates with rapid skin sclerosis and higher MRSS points. This correlation was also identical with our cohort study. Anti Ku antibody positivity is known to correlate with myositis and pulmonary hypertension. However, our analysis indicated anti Ku antibody positivity was only correlated with myositis not with pulmonary hypertension.

Conclusion:

Although the specificity of LBA was not better than conventional DID method, sensitivity was much higher than conventional DID assay. In case of anti Th/To antibody, none of sera showed positivity. Even though we have not evaluated anti Th/To antibody positivity by IP method, the frequency of anti Th/To antibody by LBA is much lower than previous report. Affinity to anti Th/To antibody by in this LBA may be affected by peptide design interfere conformation. Anti U3 RNP antibody, anti NOR90 and anti Ku antibody are usually detected by IP and western blot assay. These methods are complicated and not widely manipulated by commercial base laboratory. The LBA method provides more easy detection of auto antibody, and gives more beneficial information by measuring multiple parameters at once for characterization of SSc.


Disclosure:

K. Takagi,
None;

Y. Kawaguchi,
None;

S. Kataoka,
None;

Y. Ota,
None;

Y. Okamoto,
None;

M. Hanaoka,
None;

H. Ichida,
None;

T. Gono,
None;

Y. Katsumata,
None;

H. Yamanaka,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/line-blot-assay-a-screening-test-for-autoantibodies-in-systemic-sclerosis-ssc/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology